Quantcast
Last updated on April 16, 2014 at 17:34 EDT

Latest neurodegenerative diseases Stories

2014-03-25 08:31:05

--Funds Will Advance Novel Approach for Treatment of Alzheimer's Disease and Other Diseases of Protein Aggregation-- CAMBRIDGE, Mass., March 25, 2014 /PRNewswire/ -- NeuroPhage Pharmaceuticals, Inc. today announced the completion of a $17 million Series D financing from existing and new investors to advance the Company's lead candidate, NPT088, and potential next-generation compounds toward clinical trials. NPT088 has the potential to treat a wide range of neurodegenerative diseases,...

2014-01-31 12:25:20

U.S. Sen. Charles E. Schumer Helps Commemorate Opening of Building that Nearly Doubles Medical College's Research Space, Enhances Student Education NEW YORK, Jan. 31, 2014 /PRNewswire/ -- Weill Cornell Medical College today opened the Belfer Research Building, a state-of-the-art facility that ushers in a new era at the institution for cutting-edge, translational science. The 18-story, $650 million building, made possible through the generosity of numerous donors, nearly doubles Weill...

Pesticide Banned In The USA Linked To Alzheimer's Disease
2014-01-29 07:46:56

Rebekah Eliason for redOrbit.com – Your Universe Online For over 40 years scientists have recognized that DDT, a synthetic pesticide, harms bird habitats and is a threat to the environment. Although DDT was banned in the United States in 1972, other countries continue to use it as a pesticide. According to a new study from Rutgers University, exposure to DDT may cause increased risk and severity of Alzheimer’s disease. This is particularly true for people over 60 years of age. As...

2013-12-27 10:35:21

Researchers at Oregon Health & Science University have discovered that an antioxidant designed by scientists more than a dozen years ago to fight damage within human cells significantly helps symptoms in mice that have a multiple sclerosis-like disease. The antioxidant — called MitoQ — has shown some promise in fighting neurodegenerative diseases. But this is the first time it has been shown to significantly reverse an MS-like disease in an animal. The discovery could lead to an...

2013-12-19 08:28:23

- Novel Approach to Target Disease-driving Misfolded Proteins - CAMBRIDGE, Mass., Dec. 19, 2013 /PRNewswire/ -- NeuroPhage Pharmaceuticals, Inc. today announced that it has been awarded an $822,000 grant by The Michael J. Fox Foundation for Parkinson's Research (MJFF) for its second-generation drug candidate, NPT088, based on NeuroPhage's GAIM (general amyloid interaction motif) platform, which simultaneously targets multiple misfolded proteins central to many neurodegenerative...

2013-10-22 08:33:03

Fully Integrated Gene Therapy Company with Deep Clinical Pipeline Spun out of The Children's Hospital of Philadelphia PHILADELPHIA, Oct. 22, 2013 /PRNewswire/ -- Spark Therapeutics, a new, fully integrated company developing gene-based medicines for a wide range of debilitating diseases, announced today it has launched with a $50 million capital commitment from The Children's Hospital of Philadelphia (CHOP) to advance and commercialize multiple ongoing programs with clinical proof of...

2013-07-10 12:37:46

Presence of vascular disease reported across different neurodegenerative diseases Researchers in the Perelman School of Medicine at the University of Pennsylvania found that, across a variety of neurodegenerative diseases, cerebrovascular disease affecting circulation of blood in the brain was significantly associated with dementia. The researchers contend that people already exhibiting clinical features of Alzheimer's disease and other memory impairments may benefit from effective...

2013-07-08 16:26:00

MENLO PARK, Calif., July 8, 2013 /PRNewswire/ -- A hallmark of neurodegenerative diseases such as Alzheimer's, Parkinson's and Huntington's is that by the time symptoms appear, significant brain damage has already occurred--and currently there are no treatments that can reverse it. A team of SRI International researchers has demonstrated that measurements of electrical activity in the brains of mouse models of Huntington's disease could indicate the presence of disease before the...

2013-05-10 11:57:50

Researchers at Georgetown University Medical Center have used tiny doses of a leukemia drug to halt accumulation of toxic proteins linked to Parkinson's disease in the brains of mice. This finding provides the basis to plan a clinical trial in humans to study the effects. They say their study, published online May 10 in Human Molecular Genetics, offers a unique and exciting strategy to treat neurodegenerative diseases that feature abnormal buildup of proteins in Parkinson's disease,...

2013-05-06 08:30:03

--After Successful Pre-IND Meeting, Company On Track to Advance Lead Compound NPT002 into Clinical Trials for Alzheimer's Disease in 2014-- CAMBRIDGE, Mass., May 6, 2013 /PRNewswire/ -- NeuroPhage Pharmaceuticals, Inc., a company developing breakthrough therapies for neurodegenerative diseases, today announced that it raised $6.4 million in a private equity financing round. Merieux Developpement led the financing with participation from all current Neurophage investors, including...